IRIS PubliCatt

Marrocco, Ilaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 141
EU - Europa 118
NA - Nord America 69
Totale 328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 67
SG - Singapore 55
CN - Cina 37
IE - Irlanda 37
IT - Italia 37
ID - Indonesia 24
IN - India 22
RU - Federazione Russa 15
SE - Svezia 13
DE - Germania 8
CZ - Repubblica Ceca 3
CA - Canada 2
FI - Finlandia 2
GB - Regno Unito 2
TW - Taiwan 2
AT - Austria 1
PK - Pakistan 1
Totale 328
Salva come PNG Salva come JPEG
Città #
Ashburn 50
Singapore 48
Dublin 37
Jakarta 24
Pune 21
Milan 15
Moscow 13
Rome 9
New York 6
Halle 4
Brno 3
Busto Arsizio 3
Beijing 2
Brescia 2
Edmonton 2
Erba 2
Frankfurt am Main 2
Lappeenranta 2
Nuremberg 2
Tainan City 2
Vercelli 2
Chiswick 1
Forest City 1
London 1
Los Angeles 1
San Antonio 1
Sandston 1
Santa Clara 1
Seattle 1
Taiyuan 1
Vienna 1
Wuhan 1
Totale 262
Salva come PNG Salva come JPEG
Nome #
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 30
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity 23
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity 20
A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways 19
Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism 19
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance 16
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 16
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat 15
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 15
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors 15
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment 15
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation 14
Roles for growth factors and mutations in metastatic dissemination 14
Cancer Immunotherapy: The Dawn of Antibody Cocktails 14
Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor 13
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 13
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity 13
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis 13
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 13
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators 12
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans 11
Comparative analysis of the interaction between different flavonoids and PDIA3 9
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score 9
Totale 351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 0 0 0 0 25 16 4 0
2023/2024226 2 44 0 34 10 43 11 3 1 9 33 36
2024/202580 9 1 26 26 18 0 0 0 0 0 0 0
Totale 351